Company news

Adaptive Biotechnologies Corporation news in 2021

Adaptive Biotechnologies Corporation's news releases, calls and decks from 2021, newest first.

View company

Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

December 28, 2021

Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD Testing with the clonoSEQ® Assay in Patients with Blood Cancers at the 63rd ASH Annual Meeting

December 12, 2021

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting

December 1, 2021

Adaptive Biotechnologies Receives Updated Medicare Coverage for its Minimal Residual Disease (MRD) Assay, clonoSEQ® for Blood Cancer Patients

November 10, 2021

Adaptive Biotechnologies Reports Third Quarter 2021 Financial Results

November 2, 2021

Adaptive Biotechnologies to Report Third Quarter Financial Results on November 3, 2021

October 5, 2021

Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease

October 1, 2021

Adaptive Biotechnologies Launches Enhanced clonoSEQ® Assay Reports for Patients with Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status

September 29, 2021

Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footprint in Seattle

September 20, 2021

Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021

September 15, 2021

Adaptive Biotechnologies to Present at the Morgan Stanley Global Healthcare Conference

September 6, 2021

Adaptive Biotechnologies Reports Second Quarter 2021 Financial Results

August 3, 2021

Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer

August 3, 2021

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021

July 11, 2021

New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern

June 8, 2021

Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

June 2, 2021

Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Conferences

May 19, 2021

Adaptive Biotechnologies Reports First Quarter 2021 Financial Results

May 4, 2021

Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference

April 26, 2021

Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021

April 11, 2021

Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen

March 16, 2021

Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection

March 4, 2021

Adaptive Biotechnologies to Present at the Cowen 41st Annual Healthcare Conference

February 24, 2021

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2020 Financial Results

February 23, 2021

Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection

February 22, 2021

Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio

February 22, 2021

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

February 1, 2021

Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics

January 10, 2021

Calls in 2021

Decks in 2021